002407:SZSEDo-Fluoride New Materials Co., Ltd. Analysis
Data as of 2026-03-17 - not real-time
CN¥28.66
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Do‑Fluoride New Materials is trading at CNY 28.66, comfortably above its computed support of 27.48 but still below the 20‑day SMA of 29.83, indicating a modest near‑term cushion. The RSI sits at 42.8, suggesting neither overbought nor oversold conditions, while the MACD histogram is positive and the MACD line sits above its signal, hinting at a slight bullish bias despite an overall neutral trend. Volatility remains elevated at over 46% for the past 30 days, and the beta is exceptionally low in the computed data, implying limited market‑wide systematic risk but high idiosyncratic swings. The forward PE of 220.5 and a price‑to‑book of 4.0 signal a heavily priced stock relative to earnings prospects, especially given a trailing EPS of –0.21 and a negative profit margin. Nonetheless, the company boasts a strong cash position of CNY 5.9 bn, albeit offset by a sizable debt load, and a dividend yield of 0.7% with a zero payout ratio, raising questions about dividend sustainability. The upside/downside estimate of +57% and an “Extreme Greed” sentiment from the fear‑greed index suggest market optimism, but the fundamentals—negative ROE, thin free cash flow, and a high debt‑to‑equity ratio—temper that enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near support but below short‑term SMA
- neutral RSI and modest bullish MACD histogram
- high volatility may cause price swings
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- overvalued valuation metrics (forward PE >200)
- low profitability and negative earnings
- potential growth in lithium‑ion battery materials
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- strategic exposure to fast‑growing EV battery supply chain
- strong cash reserves despite debt
- upside potential indicated by upside/downside metric and extreme greed sentiment
Key Metrics & Analysis
Financial Health
Revenue Growth5.20%
Profit Margin-3.07%
P/E Ratio220.5
ROE-3.93%
ROA-0.50%
Debt/Equity69.58
P/B Ratio4.0
Op. Cash FlowCN¥679.4M
Free Cash FlowCN¥51.6M
Technical Analysis
TrendNeutral
RSI42.8
SupportCN¥27.48
ResistanceCN¥32.50
MA 20CN¥29.83
MA 50CN¥30.91
MA 200CN¥22.13
MACDBullish
VolumeStable
Fear & Greed Index81.48
Valuation
Target PriceCN¥45.00
Upside/Downside57.01%
GradeOvervalued
TypeBlend
Dividend Yield0.70%
Risk Assessment
Beta0.04
Volatility46.19%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.